Trials / Conditions / Stage IV Nasopharyngeal Carcinoma
Stage IV Nasopharyngeal Carcinoma
6 registered clinical trials studyying Stage IV Nasopharyngeal Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive NCT04231864 | Alain Algazi | Phase 2 |
| Unknown | PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies NCT03044743 | Yang Yang | Phase 1 / Phase 2 |
| Terminated | Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nas NCT03049358 | Stanford University | N/A |
| Completed | Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivar NCT02538510 | University of Washington | Phase 1 / Phase 2 |
| Unknown | GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma NCT01655628 | Sun Yat-sen University | Phase 2 |
| Completed | Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma NCT01616849 | Sun Yat-sen University | Phase 2 |